Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Neurology
Published: February 27, 2026
Targeting Orexin 2 Receptors in Idiopathic Hypersomnia and Narcolepsy: A Randomised Phase 1b Proof-Of-Concept Study of Alixorexton.
Journal: Journal of sleep research
Published: February 26, 2026
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis.
Journal: Muscle & nerve
Published: April 22, 2024
Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010.
Journal: Epilepsy & behavior : E&B
Published: May 30, 2015
Getting to goal in newly diagnosed type 2 diabetes using combination drug "subtraction therapy".
Journal: Metabolism: clinical and experimental
Published: March 30, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026